Clinical trial
Von Hippel-Lindau (VHL) Disease Genetic Epidemiology Study
NCT00001803 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Von Hippel-Lindau (VHL) Disease Genetic Epidemiology Study
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 26, 1999
- Completion date
- January 9, 2020
- Enrollment
- 546 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney neoplasms, von hippel lindau disease